tbuckley/cabot-search huggingface dataset:
Abstract 14773: Biventricular Conversion After Fontan Completion: A Preliminary Experience
Authors: Ilias P Doulamis, Supreet P Marathe, Breanna L Piekarski, Rebecca S Beroukhim, Gerald R Marx, Pedro J Del Nido, Sitaram M Emani
Journal: Circulation (2020)

Hypothesis: Biventricular conversion (BiVC) following takedown of Fontan circulation is feasible and results in improved hemodynamics. Methods: Retrospective analysis of patients who had takedown of Fontan circulation and conversion to BiV circulation at a single center from September 2007 to April 2020. Failing Fontan physiology was defined as Fontan circulation pressure &gt;15 mmHg. Results: There were 23 patients (median age: 10.0 (7.5-13.0) years); 15 (65%) had failing Fontan physiology and 8 (35%) underwent elective takedown of their Fontan circulation. Of the 15 patients with failing Fontan physiology, 4 had exercise intolerance or cyanosis, 3 had hepatic congestion or cirrhosis, 3 had end-organ damage and 1 patient had protein losing enteropathy; the rest 4 patients had no other sign of SVP complications. A subset of patients (n=6) underwent recruitment of the non-dominant ventricle prior to conversion. HLHS (p&lt;0.01) and sub-/aortic stenosis (p&lt;0.01) were more common in these patients. BiVC with or without staged ventricular recruitment led to a significant increase in indexed end-diastolic volume (p&lt;0.01), indexed end-systolic volume (p&lt;0.01) and ventricular mass (p&lt;0.01) of the non-dominant ventricle (14 RV, 9 LV). There were 1 (4%) early and 4 (17%) late deaths. All who underwent elective BiVC survived, while 2-year survival rate for patients with a failing Fontan circulation was 72.7% (95% CI: 37-90%) (Figure 1). The overall, 1-year reintervention free survival was 44.1% (95% CI: 21-65%). Left dominant atrioventricular canal defect (p&lt;0.01) and early year of BiVC (p=0.02) were significant predictors for mortality. Conclusions: BiVC is feasible in patients with failing Fontans, and has promising outcomes after elective takedown of Fontan circulation. A staged approach for ventricular recruitment does not seem inferior to primary BiVC. The optimal timing for BiVC in Fontan patients needs further evaluation.
Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold: An ARIA‐EAACI‐GA<sup>2</sup>LEN consensus
Authors: Jan Hagemann, Gabrielle L. Onorato, Marek Jutel, Cezmi A. Akdis, Ioana Agache, Torsten Zuberbier, Wienczyslawa Czarlewski, Joaquim Mullol, Anna Bedbrook, Claus Bachert, Kazi S. Bennoor, Karl‐Christian Bergmann, Fulvio Braido, Paulo Camargos, Luis Caraballo, Victoria Cardona, Thomas Casale, Lorenzo Cecchi, Tomas Chivato, Derek K. Chu, Cemal Cingi, Jaime Correia‐de‐Sousa, Stefano del Giacco, Dejan Dokic, Mark Dykewicz, Motohiro Ebisawa, Yehia El‐Gamal, Regina Emuzyte, Jean‐Luc Fauquert, Alessandro Fiocchi, Wytske J. Fokkens, Joao A. Fonseca, Bilun Gemicioglu, René‐Maximiliano Gomez, Maia Gotua, Tari Haahtela, Eckard Hamelmann, Tomohisa Iinuma, Juan Carlos Ivancevich, Ewa Jassem, Omer Kalayci, Przemyslaw Kardas, Musa Khaitov, Piotr Kuna, Violeta Kvedariene, Desiree E. Larenas‐Linnemann, Brian Lipworth, Michael Makris, Jorge F. Maspero, Neven Miculinic, Florin Mihaltan, Yousser Mohammad, Stephen Montefort, Mario Morais‐Almeida, Ralph Mösges, Robert Naclerio, Hugo Neffen, Marek Niedoszytko, Robyn E. O’Hehir, Ken Ohta, Yoshitaka Okamoto, Kimi Okubo, Petr Panzner, Nikolaos G. Papadopoulos, Giovanni Passalacqua, Vincenzo Patella, Ana Pereira, Oliver Pfaar, Davor Plavec, Todor A. Popov, Emmanuel P. Prokopakis, Francesca Puggioni, Filip Raciborski, Jere Reijula, Frederico S. Regateiro, Sietze Reitsma, Antonino Romano, Nelson Rosario, Menachem Rottem, Dermot Ryan, Boleslaw Samolinski, Joaquin Sastre, Dirceu Solé, Milan Sova, Cristiana Stellato, Charlotte Suppli‐Ulrik, Ioanna Tsiligianni, Antonio Valero, Arunas Valiulis, Erkka Valovirta, Tuula Vasankari, Maria Teresa Ventura, Dana Wallace, De Yun Wang, Siân Williams, Arzu Yorgancioglu, Osman M. Yusuf, Mario Zernotti, Jean Bousquet, Ludger Klimek
Journal: Allergy (2021)

Although there are many asymptomatic patients, one of the problems of COVID-19 is early recognition of the disease. COVID-19 symptoms are polymorphic and may include upper respiratory symptoms. However, COVID-19 symptoms may be mistaken with the common cold or allergic rhinitis. An ARIA-EAACI study group attempted to differentiate upper respiratory symptoms between the three diseases.A modified Delphi process was used. The ARIA members who were seeing COVID-19 patients were asked to fill in a questionnaire on the upper airway symptoms of COVID-19, common cold and allergic rhinitis.Among the 192 ARIA members who were invited to respond to the questionnaire, 89 responded and 87 questionnaires were analysed. The consensus was then reported. A two-way ANOVA revealed significant differences in the symptom intensity between the three diseases (p < .001).This modified Delphi approach enabled the differentiation of upper respiratory symptoms between COVID-19, the common cold and allergic rhinitis. An electronic algorithm will be devised using the questionnaire.
ARN-509: 前立腺癌治療目的の新規抗アンドロゲン薬
Authors: J Clegg Nicola, Wongvipat John, D Joseph James, Tran Chris, Ouk Samedy, Dilhas Anna, Chen Yu, Grillot Kate, D Bischoff Eric, Cai Ling, Aparicio Anna, Dorow Steven, Arora Vivek, Shao Gang, Qian Jing, Zhao Hong, Yang Guangbin, Cao Chunyan, Sensintaffar John, Wasielewska Teresa, R Herbert Mark, Bonnefous Celine, Darimont Beatrice, I Scher Howard, Smith-Jones Peter, Klang Mark, D Smith Nicholas, DE Stanchina Elisa, Wu Nian, Ouerfelli Ouathek, J Rix Peter, A Heyman Richard, E Jung Michael, L Sawyers Charles, H Hager Jeffrey
Journal: Cancer Research (2012)
Covid vaccine could be rolled out to children by autumn
Authors: Elisabeth Mahase
Journal: BMJ (2021)

The University of North Carolina Eshelman School of Pharmacy launched the Bill and Karen Campbell Faculty Mentoring Program (CMP) in 2006 to support scholarship-intensive junior faculty members. This report describes the origin, expectations, principles, and best practices that led to the introduction of the program, reviews the operational methods chosen for its implementation, provides information about its successes, and analyzes its strengths and limitations.
P48.02 NRG Oncology/Alliance LU005: Chemoradiation vs. Chemoradiation Plus Atezolizumab in Limited Stage Small Cell Lung Cancer
Authors: K. Higgins, C. Hu, H. Ross, S. Jabbour, D. Kozono, T. Owonikoko, B. Movsas, T. Solberg, C. Xiao, T. Williams, J. Welsh, J. Simko, X. Wang, N. Mohindra, C. Hsu, T. Stinchcombe, J. Bradley
Journal: Journal of Thoracic Oncology (2021)
MA06.10 A New Horizon of Liquid Biopsy in Thymic Epithelial Tumors: The Potential Utility of Circulating Cell-Free DNA
Authors: M. Ottaviano, M. Giuliano, M. Tortora, E. La Civita, A. Liotti, M. Longo, D. Bruzzese, M. Cennamo, V. Riccio, P. De Placido, F. Picozzi, S. Parola, B. Daniele, G. Botti, P. Formisano, F. Beguinot, S. De Placido, D. Terracciano, G. Palmieri
Journal: Journal of Thoracic Oncology (2021)
MA06.08 A Safety Study of Avelumab plus SBRT in Malignant Mesothelioma
Authors: A. Rimner, E. Yorke, D. Gelblum, A. Shepherd, D. Guttmann, A. Iqbal, R. Daly, M. Offin, J. Fiore, A. Namakydoust, H. Li, M. Mccune, E. Gelb, N. Taunk, D. Von Reibnitz, P. Adusumilli, M.S.K. Center, M. Zauderer
Journal: Journal of Thoracic Oncology (2021)
Chimeric STAR receptors using TCR machinery mediate robust responses against solid tumors
Authors: Yue Liu, Guangna Liu, Jiasheng Wang, Zhe-yu Zheng, Lemei Jia, Wei Rui, Daosheng Huang, Zhi-xiao Zhou, Liqun Zhou, Xin Wu, Song Lin, Xueqiang Zhao, Xin Lin
Journal: Science Translational Medicine (2021)

Chimeric antigen receptor T (CAR-T) cell therapies have demonstrated high response rate and durable disease control for the treatment of B cell malignancies. However, in the case of solid tumors, CAR-T cells have shown limited efficacy, which is partially attributed to intrinsic defects in CAR signaling. Here, we construct a double-chain chimeric receptor, termed as synthetic T cell receptor (TCR) and antigen receptor (STAR), which incorporates antigen-recognition domain of antibody and constant regions of TCR that engage endogenous CD3 signaling machinery. Under antigen-free conditions, STAR does not trigger tonic signaling, which has been reported to cause exhaustion of traditional CAR-T cells. Upon antigen stimulation, STAR mediates strong and sensitive TCR-like signaling, and STAR-T cells exhibit less susceptibility to dysfunction and better proliferation than traditional 28zCAR-T cells. In addition, STAR-T cells show higher antigen sensitivity than CAR-T cells, which holds potential to reduce the risk of antigen loss-induced tumor relapse in clinical use. In multiple solid tumor models, STAR-T cells prominently outperformed BBzCAR-T cells and generated better or equipotent antitumor effects to 28zCAR-T cells without causing notable toxicity. With these favorable features endowed by native TCR-like signaling, STAR-T cells may provide clinical benefit in treating refractory solid tumors.
P76.20 The Predictive Values of Non-Resistant Nncommon EGFR Mutations in Advanced Non-Small Cell Lung Cancer Patients
Authors: P. Deng, J. Tan, C. Hu, L. Cao, H. Yang, M. Li, Q. Gu, Y. Li, J. An, H. Han-Zhang
Journal: Journal of Thoracic Oncology (2021)
Attenuation of 7-ketocholesterol- and 7β-hydroxycholesterol-induced oxiapoptophagy by nutrients, synthetic molecules and oils: Potential for the prevention of age-related diseases
Authors: T. Nury, A. Yammine, I. Ghzaiel, K. Sassi, A. Zarrouk, F. Brahmi, M. Samadi, S. Rup-Jacques, D. Vervandier-Fasseur, J.P. Pais de Barros, V. Bergas, S. Ghosh, M. Majeed, A. Pande, A. Atanasov, S. Hammami, M. Hammami, J. Mackrill, B. Nasser, P. Andreoletti, M. Cherkaoui-Malki, A. Vejux, G. Lizard
Journal: Ageing Research Reviews (2021)
P01.16 Tamoxifen Might Enhance the Effect of EGFR-TKIs on EGFR-Mutant NSCLC Cells
Authors: Y. He, Q. Zhang, M. Zheng, Z. Chen, X. Wei, X. Yang, X. Gao, Y. Wu, S. Liu, Q. Zhou
Journal: Journal of Thoracic Oncology (2021)
Covid-19: EU looks to speed up vaccine rollout
Authors: Rory Watson
Journal: BMJ (2021)

Covid-19: EU looks to speed up vaccine rollout A complex web of players and concerns is impeding vaccine distribution and take-up throughout the EU.Rory Watson examines the challenges Rory WatsonTempers in Europe have been fraying as the European Union tries to get to grips with the slow rollout of covid vaccines in its 27 member countries.
A tumor-specific mechanism of T <sub>reg</sub> enrichment mediated by the integrin αvβ8
Authors: Robert I. Seed, Kenji Kobayashi, Saburo Ito, Naoki Takasaka, Anthony Cormier, Jillian M. Jespersen, Jean Publicover, Suprita Trilok, Alexis J. Combes, Nayvin W. Chew, Jocelyne Chapman, Matthew F. Krummel, Jianlong Lou, James Marks, Yifan Cheng, Jody L. Baron, Stephen L. Nishimura
Journal: Science Immunology (2021)

Tumor cells expressing integrin αvβ8 activated latent TGF-β on T cells, inducing T reg enrichment and tumor immunosuppression.
Comprehensive circRNA-microRNA-mRNA network analysis revealed the novel regulatory mechanism of Trichosporon asahii infection
Authors: Ming-Wang Zhang, Zhi-Hong Zhu, Zhi-Kuan Xia, Xin Yang, Wan-Ting Luo, Jun-Hong Ao, Rong-Ya Yang
Journal: Military Medical Research (2021)

Abstract Background Invasive Trichosporon asahii ( T. asahii ) infection frequently occurs with a high mortality in immunodeficient hosts, but the pathogenesis of T. asahii infection remains elusive. Circular RNAs (circRNAs) are a type of endogenous noncoding RNA that participate in various disease processes. However, the mechanism of circRNAs in T. asahii infection remains completely unknown. Methods RNA sequencing (RNA-seq) was performed to analyze the expression profiles of circRNAs, microRNAs (miRNAs), and mRNAs in THP-1 cells infected with T. asahii or uninfected samples. Some of the RNA-seq results were verified by RT-qPCR. Gene Ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were used to analyze the differentially expressed mRNAs. A circRNA-miRNA-mRNA network was constructed and verified by dual-luciferase reporter assay and overexpression experiments. Results A total of 46 circRNAs, 412 mRNAs and 47 miRNAs were differentially expressed at 12 h after T. asahii infection. GO and KEGG analyses showed that the differentially expressed mRNAs were primarily linked to the leukocyte migration involved in the inflammatory response, the Toll-like receptor signaling pathway, and the TNF signaling pathway. A competing endogenous RNA (ceRNA) network was constructed with 5 differentially expressed circRNAs, 5 differentially expressed miRNAs and 42 differentially expressed mRNAs. Among them, hsa_circ_0065336 was found to indirectly regulate PTPN11 expression by sponging miR-505-3p. Conclusions These data revealed a comprehensive circRNA-associated ceRNA network during T. asahii infection, thus providing new insights into the pathogenesis of the T. asahii -host interactions.
Register-based metrics of years lived with disability associated with mental and substance use disorders: a register-based cohort study in Denmark
Authors: Nanna Weye, Damian F Santomauro, Esben Agerbo, Maria Klitgaard Christensen, Kim Moesgaard Iburg, Natalie C Momen, Preben Bo Mortensen, Carsten Bøcker Pedersen, Harvey A Whiteford, John J McGrath, Oleguer Plana-Ripoll
Journal: The Lancet Psychiatry (2021)
P52.06 “High Tumor Burden” in Metastatic Non-Small Cell Lung Cancer: Defining the Concept
Authors: O. Higuera, A. Moreno Paul, A.L. Ortega Granados, D. Pérez Parente, P. Ruiz-Gracia, L. Sáenz Cuervo-Arango, L. Vilà
Journal: Journal of Thoracic Oncology (2021)
Association of spontaneous abortion with all cause and cause specific premature mortality: prospective cohort study
Authors: Yi-Xin Wang, Lidia Mínguez-Alarcón, Audrey J Gaskins, Stacey A Missmer, Janet W Rich-Edwards, JoAnn E Manson, An Pan, Jorge E Chavarro
Journal: BMJ (2021)

Abstract Objective To investigate the association of spontaneous abortion with the risk of all cause and cause specific premature mortality (death before the age of 70). Design Prospective cohort study. Setting The Nurses’ Health Study II (1993-2017), United States. Participants 101 681 ever gravid female nurses participating in the Nurses’ Health Study II. Main outcomes measures Lifetime occurrence of spontaneous abortion in pregnancies lasting less than 6 months, determined by biennial questionnaires. Hazard ratios and 95% confidence intervals for all cause and cause specific premature death according to the occurrence of spontaneous abortion, estimated with time dependent Cox proportional hazards models. Results During 24 years of follow-up, 2936 premature deaths were recorded, including 1346 deaths from cancer and 269 from cardiovascular disease. Crude all cause mortality rates were comparable for women with and without a history of spontaneous abortion (1.24 per 1000 person years in both groups) but were higher for women experiencing three or more spontaneous abortions (1.47 per 1000 person years) and for women reporting their first spontaneous abortion before the age of 24 (1.69 per 1000 person years). The corresponding age adjusted hazard ratios for all cause premature death during follow-up were 1.02 (95% confidence interval 0.94 to 1.11), 1.39 (1.03 to 1.86), and 1.27 (1.11 to 1.46), respectively. After adjusting for confounding factors and updated dietary and lifestyle factors, the occurrence of spontaneous abortion was associated with a hazard ratio of 1.19 (95% confidence interval 1.08 to 1.30) for premature mortality during follow-up. The association was stronger for recurrent spontaneous abortions (hazard ratio 1.59, 95% confidence interval 1.17 to 2.15 for three or more spontaneous abortions; 1.23, 1.00 to 1.50 for two; and 1.16, 1.05 to 1.28 for one compared with none), and for spontaneous abortions occurring early in a woman’s reproductive life (1.32, 1.14 to 1.53 for age ≤23; 1.16, 1.01 to 1.33 for ages 24-29; and 1.12, 0.98 to 1.28 for age ≥30 compared with none). When cause specific mortality was evaluated, the association of spontaneous abortion with premature death was strongest for deaths from cardiovascular disease (1.48, 1.09 to 1.99). Spontaneous abortion was not related to premature death from cancer (1.08, 0.94 to 1.24). Conclusions Spontaneous abortion was associated with an increased risk of premature mortality, particularly death from cardiovascular disease.
FP07.17 The Impact of Blood Based Host Immune Profile to Identify Aggressive Early Stage NSCLC
Authors: E. Schaefer, P. Walker, R. Mitchell, D. Oubre, N. Nagajothi, J. Tan, M. Khalil, J. Dubay, J. Orsini, W. Akerley
Journal: Journal of Thoracic Oncology (2021)
Robert John Ham
Authors: Frank Cross
Journal: BMJ (2021)

Robert John Ham (“Bob”) started his medical training in 1966, studied for a BSc (pharmacology), and qualified in 1972. He completed his house and senior house officer jobs at both Whitechapel and Mile End hospitals and then moved to Basildon District Hospital as registrar in surgery in 1975-77. He was awarded the fellowship of the Royal College of Surgeons in 1976. He returned to the London Hospital, Queen Elizabeth Hosp0ital for Children in Hackney, and Whipps Cross Hospital between 1977 and …
Abstract 351: In-vivo Stem Cell Tracking Using Ultrasound Imaging
Authors: Xiaoping Leng, Jianjun Wang, Huili Fu, Andrew Fisher, Xucai Chen, Flordeliza S Villanueva
Journal: Circulation (2009)

Background: Exogenous delivery of reparative cells is a promising new approach to treating cardiovascular disease. Clinical application of cell therapies is limited by a lack of imaging methods for...
P41.05 Challenges of Implementing Lung Cancer Screening in Brazil: Preliminary Results of a Multicenter Group
Authors: N. Rizvi, S. Camargo, C.E. Escovar, R. Chate, G. Szarf, G. Teles, M. Guimarães, J. Gross, P. Barbosa, R. Chiarantano, R. Reis, E. Mauad, M. Ghefter, P. Sarmento, R. Pereira, J. Rocha, M. Albuquerque, J.P. Franceschini, B. Hochhegger
Journal: Journal of Thoracic Oncology (2021)
MA12.09 Retrospective Analysis of DIPNECH and Carcinoid Tumorlets as Precursors to Invasive Pulmonary Carcinoid Tumors
Authors: T.Y. Sun, A. Codima, G. Hwang, K. Hornbacker, D. Pancirer, N. Lui, R. Raj, P. Kunz, S. Padda
Journal: Journal of Thoracic Oncology (2021)
GMC reduces investigations of minor cases that pose no risk to public safety
Authors: Clare Dyer
Journal: BMJ (2021)

The General Medical Council (GMC) has issued new guidance for staff triaging complaints, which should significantly cut the number of cases going ahead where doctors are accused of low level violence or dishonesty outside their professional practice.1

The aim is to reduce the number of cases going through full investigations that end in a finding that the doctor’s fitness to practise is not impaired, with no action taken or a warning given, and to focus resources on cases that pose a genuine risk to public protection.

The previous guidance presumed that all allegations of violence or dishonesty would be referred to a tribunal unless there were exceptional reasons not to refer. From September 2018 to June 2020, 33 tribunal hearings involving allegations of violence or dishonesty concluded with a finding of no impairment and either no action or …
Association of genetic liability to smoking initiation with e-cigarette use in young adults: A cohort study
Authors: Jasmine N. Khouja, Robyn E. Wootton, Amy E. Taylor, George Davey Smith, Marcus R. Munafò
Journal: PLoS Medicine (2021)

Background Tobacco smoking and e-cigarette use are strongly associated, but it is currently unclear whether this association is causal, or due to shared factors that influence both behaviours such as a shared genetic liability. The aim of this study was to investigate whether polygenic risk scores (PRS) for smoking initiation are associated with ever use of e-cigarettes. Methods and findings Smoking initiation PRS were calculated for young adults ( N = 7,859, mean age = 24 years, 51% male) of European ancestry in the Avon Longitudinal Study of Parents and Children, a prospective birth cohort study initiated in 1991. PRS were calculated using the GWAS &amp; Sequencing Consortium of Alcohol and Nicotine use (GSCAN) summary statistics. Five thresholds ranging from 5 × 10 −8 to 0.5 were used to calculate 5 PRS for each individual. Using logistic regression, we investigated the association between smoking initiation PRS and the main outcome, self-reported e-cigarette use ( n = 2,894, measured between 2016 and 2017), as well as self-reported smoking initiation and 8 negative control outcomes (socioeconomic position at birth, externalising disorders in childhood, and risk-taking in young adulthood). A total of 878 young adults (30%) had ever used e-cigarettes at 24 years, and 150 (5%) were regular e-cigarette users at 24 years. We observed positive associations of similar magnitude between smoking initiation PRS (created using the p &lt; 5 × 10 −8 threshold) and both smoking initiation (odds ratio (OR) = 1.29, 95% CI 1.19 to 1.39, p &lt; 0.001) and ever e-cigarette use (OR = 1.24, 95% CI 1.14 to 1.34, p &lt; 0.001) by the age of 24 years, indicating that a genetic predisposition to smoking initiation is associated with an increased risk of using e-cigarettes. At lower p -value thresholds, we observed an association between smoking initiation PRS and ever e-cigarette use among never smokers. We also found evidence of associations between smoking initiation PRS and some negative control outcomes, particularly when less stringent p -value thresholds were used to create the PRS, but also at the strictest threshold (e.g., gambling, number of sexual partners, conduct disorder at 7 years, and parental socioeconomic position at birth). However, this study is limited by the relatively small sample size and potential for collider bias. Conclusions Our results indicate that there may be a shared genetic aetiology between smoking and e-cigarette use, and also with socioeconomic position, externalising disorders in childhood, and risky behaviour more generally. This indicates that there may be a common genetic vulnerability to both smoking and e-cigarette use, which may reflect a broad risk-taking phenotype.
P14.14 PTPRD: A Positive Predictive Biomarker for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer
Authors: J. Shen, H. Zhou, J. Liu, Y. Zhang, T. Zhou, S. Hong, Y. Zhao, Y. Yang, H. Zhao, Y. Huang, W. Fang, L. Zhang
Journal: Journal of Thoracic Oncology (2021)
P52.02 Staging Lung Cancer: Are All Suspicious Lymph Nodes Pathologic?
Authors: M. Iglesias, M.T. Tsukazan, A. Vigo, L. Bittencourt Hinrichsen, L.E. Canton, R. Ribeiro, A.H. Furlanetto, G.F. Schneider, M.L. Santos, P.A. Schulze, J.A. Figueiredo Pinto
Journal: Journal of Thoracic Oncology (2021)
Body Weight Changes During Pandemic-Related Shelter-in-Place in a Longitudinal Cohort Study
Authors: Anthony L. Lin, Eric Vittinghoff, Jeffrey E. Olgin, Mark J. Pletcher, Gregory M. Marcus
Journal: JAMA Network Open (2021)

Susan J. Woolford, MD, MPH; Margo Sidell, ScD; Xia Li, MSc; Veronica Else, RN, MSN; Deborah R. Young, PhD; Ken Resnicow, PhD; Corinna Koebnick, PhD
P40.03 Report on a Phytochemical-rich Dietary Intervention Trial to Prevent Lung Cancer: Implementation in a High-Risk Lung Screening Clinic
Authors: M. Bittoni, A. Bibi, N. Williams, M. Mendelson, E. Grainger, Y. Vodovitz, K. Riedl, S. Clinton, D. Carbone, D. Spakowicz
Journal: Journal of Thoracic Oncology (2021)
HLA class I allele–lacking leukocytes predict rare clonal evolution to MDS/AML in patients with acquired aplastic anemia
Authors: Kohei Hosokawa, Hiroki Mizumaki, Takeshi Yoroidaka, Hiroyuki Maruyama, Tatsuya Imi, Noriaki Tsuji, Ryota Urushihara, Mikoto Tanabe, Yoshitaka Zaimoku, Mai Anh Thi Nguyen, Dung Cao Tran, Ken Ishiyama, Hirohito Yamazaki, Takamasa Katagiri, Hiroyuki Takamatsu, Kazuyoshi Hosomichi, Atsushi Tajima, Fumihiro Azuma, Seishi Ogawa, Shinji Nakao
Journal: Blood (2021)